The minimal important difference for residual volume in patients with severe emphysema

European Respiratory Journal

Volumn 40, Issue 5, 2012, Pages 1137-1141

  Hartman, Jorine E ^a   Ten Hacken, Nick H T ^a   Klooster, Karin ^a   Boezen, H Marike ^a   De Greef, Mathieu H G ^a   Slebos, Dirk Jan ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Chronic obstructive pulmonary disease; Hyperinflation; Lung volume reduction

Indexed keywords

ADULT; ARTICLE; BODY PLETHYSMOGRAPHY; CONTROLLED STUDY; CORRELATION COEFFICIENT; DISEASE SEVERITY; EFFECT SIZE; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; HYPERINFLATION; LINEAR REGRESSION ANALYSIS; LUNG EMPHYSEMA; MAJOR CLINICAL STUDY; MALE; MINIMAL IMPORTANT DIFFERENCE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESIDUAL VOLUME; STATISTICAL PARAMETERS; TOTAL LUNG CAPACITY;

BRONCHOSCOPY; FEMALE; HUMANS; MALE; MIDDLE AGED; PULMONARY EMPHYSEMA; RESIDUAL VOLUME; SEVERITY OF ILLNESS INDEX;

EID: 84868598012     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00219111     Document Type: Article

References (22)

1. Cooper CB. The connection between chronic obstructive pulmonary disease symptoms and hyperinflation and its impact on exercise and function. Am J Med 2006; 119: 21-31.
2. Garcia-Rio F, Lores V, Mediano O, et al. Daily physical activity in patients with chronic obstructive pulmonary disease is mainly associated with dynamic hyperinflation. Am J Respir Crit Care Med 2009; 180: 506-512.
3. Puente-Maestu L, Stringer WW. Hyperinflation and its management in COPD. Int J Chron Obstruct Pulmon Dis 2006; 1: 381-400.
4. Tiong LU, Davies R, Gibson PG, et al. Lung volume reduction surgery for diffuse emphysema. Cochrane Database Syst Rev 2006; 4: CD001001.
5. Herth FJ, Gompelmann D, Ernst A, et al. Endoscopic lung volume reduction. Respiration 2010; 79: 5-13.
6. Slebos DJ, Klooster K, Ernst A, et al. Bronchoscopic lung volume reduction coil treatment of patients with severe heterogeneous emphysema. Chest 2011; [Epub ahead of print DOI: 10.1378/chest.11-0730].
7. Sciurba FC, Ernst A, Herth FJ, et al. A randomized study of endobronchial valves for advanced emphysema. N Engl J Med 2010; 363: 1233-1244.
8. Hopkinson NS, Toma TP, Hansell DM, et al. Effect of broncho-scopic lung volume reduction on dynamic hyperinflation and exercise in emphysema. Am J Respir Crit Care Med 2005; 171: 453-460.
9. Copay AG, Subach BR, Glassman SD, et al. Understanding the minimum clinically important difference: a review of concepts and methods. Spine J 2007; 7: 541-546.
10. Shah PL, Slebos DJ, Cardoso PF, et al. Bronchoscopic lung-volume reduction with Exhale Airway Stents for Emphysema (EASE trial): randomised, sham-controlled, multicentre trial. Lancet 2011; 378: 997-1005.
11. Wanger J, Clausen JL, Coates A, et al. Standardisation of the measurement of lung volumes. Eur Respir J 2005; 26: 511-522.
12. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J 2005; 26: 319-338.
13. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002; 166: 111-117.
14. Jones PW, Quirk FH, Baveystock CM. The St George's Respiratory Questionnaire. Respir Med 1991; 85: Suppl. B, 25-31.
15. Guyatt GH, Osoba D, Wu AW, et al. Methods to explain the clinical significance of health status measures. Mayo Clin Proc 2002; 77: 371-383.
16. Revicki D, Hays RD, Cella D, et al. Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. J Clin Epidemiol 2008; 61: 102-109.
17. Donohue JF. Minimal clinically important differences in COPD lung function. COPD 2005; 2: 111-124.
18. Puhan MA, Chandra D, Mosenifar Z, et al. The minimal important difference of exercise tests in severe COPD. Eur Respir J 2011; 37: 784-790.
19. Jones PW. St. George's Respiratory Questionnaire: MCID. COPD 2005; 2: 75-79.
20. Holland AE, Hill CJ, Rasekaba T, et al. Updating the minimal important difference for six-minute walk distance in patients with chronic obstructive pulmonary disease. Arch Phys Med Rehabil 2010; 91: 221-225.
21. Troosters T. How important is a minimal difference? Eur Respir J 2011; 37: 755-756.
22. Fessler HE, Scharf SM, Permutt S. Improvement in spirometry following lung volume reduction surgery: application of a physiologic model. Am J Respir Crit Care Med 2002; 165: 34-40.